CURRENT NEWS

• 02.07.2021
  Siegfried Restarts Production After Cyber Attack
• 02.07.2021
  Standigm Secures Strategic Investment From SK Chemicals for Expanding Its AI-Drug Development Capacity
• 02.07.2021
  Sesen Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 02.07.2021
  Sartorius Stedim Biotech Strengthens Product Portfolio for Cell and Gene Therapies by Acquiring a Majority Stake in CellGenix
• 02.07.2021
  Genetron Health Enters into Platform Partnership with World Economic Forum
• 02.07.2021
  Celemics to Supply Genomic Diagnostic Platform to China
• 02.07.2021
  SK Biopharm Aims to Be Global Top-10 Health Firm by 2030
• 02.07.2021
  Eurofins Opens Europe-Wide COVID-19 Testing Centre Network to Facilitate Summer Travel
• 02.07.2021
  Eurofins Develops Most Comprehensive COVID-19 Testing Network in the UK to Enable International Travel
• 01.07.2021
  Nexomics Introduces New Magegement Team: Dr. Rong Xiao as CSO and Dr. Gaohua Liu as CEO
• 01.07.2021
  Pamgene, Novigenix And Radboud University Medical Center Secure Eurostars Funding To Develop A Multi-omic Predictive Immunotherapy Response Test For Bladder Cancer Patients
• 01.07.2021
  Xintela Incorporates Subsidiary in Australia
• 01.07.2021
  Adalta Secures AD-214 Resupply Under KBI Biopharma MSA
• 01.07.2021
  HERMES PHARMA Announces Spin-Out from HERMES Arzneimittel
• 01.07.2021
  Supreme Court Sets Aside Indoco's Request to Lift Injunction on Launch of Generic Apixaban
• 01.07.2021
  22nd Century Announces Restructuring of Panacea Investment, Expansion of Cannabis Franchise Capabilities
• 01.07.2021
  Pressure BioSciences Novel UST Platform Delivers Breakthrough Nanoemulsion Processing for One of the World's Most Potent Antioxidants - Astaxanthin
• 01.07.2021
  Clinical Trial ∣ Zejing Pharma Initiated a Phase III Clinical Trial of Jacktinib Hydrochloride Tablets in the Treatment of Severe Alopecia Areata
• 01.07.2021
  Unchained Labs Does It Again for Gene Therapy and Vaccine Researchers, Adds Nanoparticle Suite to Stunner
• 01.07.2021
  Bioasis Announces the Appointment of Dave Jenkins as Chief Financial Officer

Records per page:

Page

Total: 24132 records.